KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Sales (2016 - 2025)

Biogen (BIIB) has 17 years of Return on Sales data on record, last reported at 0.02% in Q4 2025.

  • For Q4 2025, Return on Sales fell 13.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.13%, down 4.0%, while the annual FY2025 figure was 0.13%, 4.0% down from the prior year.
  • Return on Sales reached 0.02% in Q4 2025 per BIIB's latest filing, down from 0.18% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.45% in Q3 2022 and bottomed at 0.06% in Q3 2023.
  • Average Return on Sales over 5 years is 0.19%, with a median of 0.17% recorded in 2023.
  • Peak YoY movement for Return on Sales: soared 34bps in 2022, then tumbled -51bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then skyrocketed by 1642bps to 0.22% in 2022, then grew by 20bps to 0.26% in 2023, then crashed by -58bps to 0.11% in 2024, then crashed by -120bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.02% in Q4 2025, 0.18% in Q3 2025, and 0.24% in Q2 2025.